Literature DB >> 14603253

Control of microtubule stability by the RASSF1A tumor suppressor.

Limin Liu1, Stella Tommasi, Dong-Hyun Lee, Reinhard Dammann, Gerd P Pfeifer.   

Abstract

The RAS association domain family 1A (RASSF1A) gene is silenced by DNA methylation in over 50% of all solid tumors of different histological types. However, the biochemical function of the RASSF1A protein is unknown. We show that RASSF1A colocalizes with microtubules in interphase and decorates spindles and centrosomes during mitosis. RASSF1A has a strong cytoprotective activity against the microtubule-destabilizing drug nocodazole, and against cold-treatment in vivo. Conversely, loss of RASSF1 in RASSF1-/- mouse embryonic fibroblasts renders the cells more sensitive to nocodazole-induced depolymerization of microtubules. The domain required for both microtubule association and stabilization was mapped to a 169 amino-acid fragment that contains the RAS association domain. Overexpression of RASSF1A induces mitotic arrest at metaphase with aberrant mitotic cells reminiscent of such produced by the microtubule-stabilizing drug paclitaxel (taxol), including monopolar spindles, or complete lack of a mitotic spindle. Altered microtubule stability in cells lacking RASSF1A is likely to affect spindle assembly and chromosome attachment, processes that need to be carefully controlled to protect cells from genomic instability and transformation. In addition, knowledge of the microtubule-targeting function of RASSF1 may aid in the development of new anticancer drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14603253     DOI: 10.1038/sj.onc.1206984

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  63 in total

1.  The RASSF1A tumor suppressor regulates XPA-mediated DNA repair.

Authors:  Howard Donninger; Jennifer Clark; Francesca Rinaldo; Nicholas Nelson; Thibaut Barnoud; M Lee Schmidt; Katharine R Hobbing; Michele D Vos; Brian Sils; Geoffrey J Clark
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

2.  c-Src but not Fyn promotes proper spindle orientation in early prometaphase.

Authors:  Yuji Nakayama; Yuki Matsui; Yumi Takeda; Mai Okamoto; Kohei Abe; Yasunori Fukumoto; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

3.  Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation.

Authors:  Christine Bee; Anna Moshnikova; Christopher D Mellor; Justin E Molloy; Yulia Koryakina; Benjamin Stieglitz; Andrei Khokhlatchev; Christian Herrmann
Journal:  J Biol Chem       Date:  2010-03-25       Impact factor: 5.157

4.  The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.

Authors:  Min Sup Song; Su Jung Song; So Yeon Kim; Hyun Jung Oh; Dae-Sik Lim
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

Review 5.  Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics.

Authors:  Faisal Saeed Khan; Ijaz Ali; Ume Kalsoom Afridi; Muhammad Ishtiaq; Rashid Mehmood
Journal:  Hepatol Int       Date:  2016-06-07       Impact factor: 6.047

Review 6.  Crosstalk of cell polarity signaling pathways.

Authors:  Tomáš Mazel
Journal:  Protoplasma       Date:  2017-03-14       Impact factor: 3.356

7.  Cullin-4A·DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis.

Authors:  Lingyan Jiang; Rong Rong; M Saeed Sheikh; Ying Huang
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

Review 8.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

9.  Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras.

Authors:  Maria Praskova; Andrei Khoklatchev; Sara Ortiz-Vega; Joseph Avruch
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

Review 10.  DNA methylation in hepatocellular carcinoma.

Authors:  Iris Tischoff; Andrea Tannapfe
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.